ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,927.49
-0.23%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Millendo Therapeutics Inc (MLND)

  7. Millendo Therapeutics Inc (MLND) Noticias

MLND

Millendo Therapeutics (MLND)

Millendo Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:MLND
FechaHoraFuenteTítuloSímboloCompañía
20/06/202315:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MLNDMillendo Therapeutics Inc
16/06/202315:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MLNDMillendo Therapeutics Inc
10/05/202315:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MLNDMillendo Therapeutics Inc
01/05/202315:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:MLNDMillendo Therapeutics Inc
01/05/202315:12Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MLNDMillendo Therapeutics Inc
14/02/202313:57Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MLNDMillendo Therapeutics Inc
14/02/202311:11Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MLNDMillendo Therapeutics Inc
04/10/202207:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MLNDMillendo Therapeutics Inc
21/06/202207:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:MLNDMillendo Therapeutics Inc
31/05/202206:35Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MLNDMillendo Therapeutics Inc
27/05/202208:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MLNDMillendo Therapeutics Inc
16/05/202217:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:MLNDMillendo Therapeutics Inc
11/05/202214:43Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MLNDMillendo Therapeutics Inc
02/05/202215:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MLNDMillendo Therapeutics Inc
22/04/202215:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:MLNDMillendo Therapeutics Inc
01/04/202205:24Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:MLNDMillendo Therapeutics Inc
29/03/202215:59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MLNDMillendo Therapeutics Inc
30/09/202109:47Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MLNDMillendo Therapeutics Inc
23/07/202115:39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MLNDMillendo Therapeutics Inc
22/06/202115:00GlobeNewswire Inc.Tempest and Millendo Announce Stockholder Approval of MergerNASDAQ:MLNDMillendo Therapeutics Inc
11/06/202116:20Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MLNDMillendo Therapeutics Inc
10/05/202116:13Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MLNDMillendo Therapeutics Inc
13/04/202112:50Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MLNDMillendo Therapeutics Inc
13/04/202109:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MLNDMillendo Therapeutics Inc
30/03/202106:26TipRanksMillendo To Merge With Tempest Therapeutics; Shares TankNASDAQ:MLNDMillendo Therapeutics Inc
29/03/202106:00Business WireTempest and Millendo Announce Proposed Merger AgreementNASDAQ:MLNDMillendo Therapeutics Inc
05/01/202108:00Business WireMillendo Therapeutics Provides Pipeline and Business UpdateNASDAQ:MLNDMillendo Therapeutics Inc
09/11/202007:30Business WireMillendo Therapeutics Reports Third Quarter 2020 Operating and Financial ResultsNASDAQ:MLNDMillendo Therapeutics Inc
24/09/202007:30Business WireMillendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R AntagonistNASDAQ:MLNDMillendo Therapeutics Inc
03/09/202007:30Business WireMillendo Therapeutics to Participate in September Investor ConferencesNASDAQ:MLNDMillendo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MLND

Su Consulta Reciente

ASX
VGS
Vanguard Investments Aus...
LSE
GGT
Global Gaming
LSE
XBGG
Xesg Ga B 3d �
XE
JNP
Juniper Networks Dl 01
EU
AAFD
FCT Auto ABS French Loan...
LSE
YI60
Citi Fun 25
COIN
NOAHPETH
NOAH DECENTRALIZED STATE COIN
LSE
FO68
Citi Fun 24
NASDAQ
AAXRYXX
BofA Finance LLC Issuer ...
BITMOT
859356
Ifc Tf 1,375% Ot24 Usd
NASDAQ
SPWH
Sportsmans Warehouse
COIN
BALEUR
Balancer
BOV
BLSA6L
Brilasa Britagem Laminac... PNB
COIN
XGSGBP
EU
IWQE
Ishares Iv
ASX
NCMKOT
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados